These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26960364)

  • 1. Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease.
    Zeng ZY; Gui C; Li L; Wei XM
    Chin Med J (Engl); 2016 Mar; 129(6):631-5. PubMed ID: 26960364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiopoietin-2 concentrations of post-PCI are correlated with the parameters of renal function in patients with coronary artery disease.
    Jian W; Li L; Wei XM; Guan JH; Yang GL; Gui C
    Medicine (Baltimore); 2019 Jan; 98(1):e13960. PubMed ID: 30608432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in serum angiopoietin-1, angiopoietin-2, and angiopoietin-2/angiopoietin-1 ratio in acute myocardial infarction patients treated with primary percutaneous coronary intervention.
    Chen S; Guo L; Cui M; Sun L; Mi L
    Biomarkers; 2012 Aug; 17(5):441-6. PubMed ID: 22642477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris.
    Gui C; Li SK; Nong QL; Du F; Zhu LG; Zeng ZY
    Cardiovasc Diabetol; 2013 Feb; 12():34. PubMed ID: 23421785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circulation of patients with and without coronary collateral vessels.
    Mitsuma W; Kodama M; Hirono S; Ito M; Ramadan MM; Tanaka K; Hoyano M; Saigawa T; Kashimura T; Fuse K; Okura Y; Aizawa Y
    Circ J; 2007 Mar; 71(3):343-7. PubMed ID: 17322632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes and significance of serum angiopoietin-2 levels in patients with coronary heart disease.
    Wang X; Yong H; Mi L; Bai Y; Guo L; Gao W; Cui M; Zhang Y
    Biomarkers; 2012 Dec; 17(8):745-9. PubMed ID: 23190218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Jian W; Guan JH; Zheng WB; Mo CH; Xu YT; Huang QL; Wei CM; Wang C; Yang ZJ; Yang GL; Gui C
    Aging (Albany NY); 2020 Mar; 12(6):5140-5151. PubMed ID: 32182213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related change of serum angiogenic factor levels in patients with coronary artery disease.
    Meng R; Pei Z; Chen B; Ma R; Zhang C; Chen B; Zhang A; Wu T; Liu D; Dong Y
    Acta Cardiol; 2009 Dec; 64(6):735-40. PubMed ID: 20128148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the Serum Platelet-Derived Growth Factor, Angiopoietin-1, and Severity of Coronary Heart Disease.
    Pang S; Tao Z; Min X; Zhou C; Pan D; Cao Z; Wang X
    Cardiol Res Pract; 2020; 2020():3602608. PubMed ID: 32963822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.
    Güngör B; Alper AT; Ozcan KS; Ekmekçi A; Karadeniz FÖ; Mutluer FO; Kaya A; Karataş B; Osmonov D; Bolca O
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):965-72. PubMed ID: 24402881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.
    Jian W; Li L; Wei XM; Wu CQ; Gui C
    Medicine (Baltimore); 2019 Feb; 98(5):e14216. PubMed ID: 30702576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
    Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
    Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ischemic J wave before and post percutaneous coronary intervention in patients with coronary artery disease].
    Guo WY; Li B; Zhang XM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Dec; 39(12):1083-7. PubMed ID: 22336499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
    Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
    Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.